TEVIMBRA: payments to doctors
Payments that named TEVIMBRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 3,297
- Transactions
- 5,903
- Average per transaction
- $220
The per-transaction average — $220 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,297 providers the average total is $395, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Beone Medicines USA, Inc. | $995,365 | 76.5% |
| Beigene USA, Inc. | $304,330 | 23.4% |
| Beigene Switzerland GmbH | $1,500 | 0.1% |